Rutgers requiring students to be vaccinated for fall semester
It's one of the first universities in the region to have such a vaccine requirement.
Watch CBS News
It's one of the first universities in the region to have such a vaccine requirement.
President Biden has set a new goal of administering 200 million coronavirus vaccine doses by the end of April. It comes as at least 20 states are reporting a rise in new cases. As CBS News' Mola Lenghi reports, officials say the variant first found in the U.K. may be to blame. Then, Dr. Len Horovitz, a pulmonary specialist at Lenox Hill Hospital, joins CBSN's Lana Zak with his insight.
In his first formal news conference, President Biden defended his administration's policy at the U.S.-Mexico border, and revealed his plans to run for reelection in 2024. CBS News senior White House and political reporter Ed O'Keefe, CBSN Washington reporter Caitlin Huey-Burns, Associated Press White House reporter Zeke Miller and Washington Post political reporter Eugene Scott join CBSN's "Red & Blue" host Elaine Quijano with analysis.
New coronavirus cases are on the rise in many states, but nowhere are cases spiking more than in Michigan. Mola Lenghi takes a look.
British drug maker revised the numbers on a late-stage trial after U.S. officials called them into question, in a highly unusual public spat.
A survey experiment suggests there are groups Biden and Trump could target, but there are limits to their influence.
The airline's chief pilot told other pilots they would need to "attempt to schedule later in the month" so the airline could maintain "operational reliability."
CBS News got exclusive access to a world-first: a clinical trial to determine whether giving different COVID-19 vaccines for the first and second dose works as well as using the same shot twice. Charlie D'Agata spoke to the scientists and the volunteers to learn more.
With air travel increasing around the U.S., some are questioning if it's safe to travel once vaccinated. Dr. Susannah Hills spoke with Anne-Marie Green and Vladimir Duthiers on CBSN about what to know before you travel abroad and how the pandemic may progress based on new data from the World Health Organization.
Scientists hopeful this round won't be as bad as the first, but they warn it could be if people don't adhere to government guidelines.
And it's not just a one-time offer — vaccinated individuals can go back every single day and continue getting free doughnuts through all of 2021.
The shots often lead to lymph node inflammation, often a sign of cancer. Some doctors interpret the inflammation seen on mammograms post-inoculation as evidence of possible cancer.
AstraZeneca is facing another setback after U.S. health officials raised concerns about the company's vaccine trial data using "outdated information." As Meg Oliver reports, the new questions come as the U.S. makes great strides in its race to vaccinate. Dr. Teresa Amato, the director of emergency medicine at Long Island Jewish Forest Hills, then joins CBSN's Elaine Quijano with more.
The National Institute of Allergy and Infectious diseases is raising concerns about AstraZeneca's COVID-19 vaccine trial results, which included some apparently outdated information. Tanya Rivero spoke with Dr. Eric Cioe-Peña, an emergency room physician and director of Global Health at Northwell Health, about the significance.
New questions are being raised about the effectiveness of the AstraZeneca vaccine as health officials say a U.S. trial of the coronavirus shot may have used outdated information. Meg Oliver has more.
AstraZeneca is facing questions after an independent review board said the company included outdated information from its U.S. COVID vaccine trial. It comes as the head of the CDC warns the U.S. could face another avoidable surge in cases. CBS News reporter Alex Tin joins CBSN's "Red & Blue" anchor Elaine Quijano with more on the controversy and the latest vaccintion numbers.
AstraZeneca may have used "outdated information" when it released data from a late-stage trial of its COVID-19 vaccine early Monday, federal officials say. The Data and Safety Monitoring Board (DSMB) said late in the day it "was concerned" about the information the British drugmaker made public about the large-scale U.S. trial of the vaccine it developed along with Oxford University. CBS News medical contributor Dr. David Agus joins "CBS This Morning" to address the news.
Nearly 45 million people in the U.S. are now fully vaccinated. CBS News medical contributor, Dr. David Agus, joins "CBS This Morning" with guidance on what fully vaccinated Americans can look forward to.
Scientists behind an Oxford University-led trial in the U.K. say the results could help address both vaccine shortages, and worrying coronavirus variants.
Voters in Israel are heading to the polls in an election that’s become a referendum on Prime Minister Benjamin Netanyahu, a leader facing serious corruption charges – but who also delivered a vaccination program that has immunized most of the adult population in record time. Elizabeth Palmer spoke to potential voters in the lead-up to election day.
Despite progress on the vaccine front, health experts warn the nation is at risk of another COVID surge if safety measures are relaxed while variants spread. CBS News correspondents Meg Oliver and David Begnaud bring us the latest on efforts to fight the pandemic, then Dr. Dara Kass, an ER doctor and medical contributor for Yahoo News, joins CBSN with analysis.
In case you needed another reason to get your COVID-19 vaccination, Krispy Kreme is sweetening the deal by giving free doughnuts to anyone with proof of vaccination, all year long. CBSN's Tanya Rivero has the details.
AstraZeneca has released clinical trial results showing its vaccine is 79% effective against symptomatic cases of COVID-19 and 100% effective at preventing severe disease and hospitalizations. Dr. Ron Elfenbein spoke with Anne-Marie Green and Vladimir Duthiers on CBSN about why these results are so promising, and the wild scenes in Florida where spring break tourists are defying curfews and COVID restrictions.
AstraZeneca says advanced trial data from a U.S. study on the COVID-19 vaccine it developed along with Oxford University shows it is 79% effective in preventing symptomatic illness and 100% effective against severe illness and hospitalization. Dr. David Agus joined "CBS This Morning" to explain more.
Israel is set to hold its fourth national election in two years, and Prime Minister Benjamin Netanyahu has been running for reelection on the efficiency of the nation's vaccine rollout. Current polls show Netanyahu with a 50-50 shot at victory. Elizabeth Palmer has more.